[Case Study] Keiji Okinaka “A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment” (AMR Alliance Japan, September 6, 2021 )
date : 9/6/2021
Tags: AMR
![[Case Study] Keiji Okinaka “A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment” (AMR Alliance Japan, September 6, 2021 )](https://hgpi.org/en/wp-content/uploads/sites/2/AMR-case01_ENG.jpg)
AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) has begun a project to publish case studies showing actual cases in which antimicrobials were and were not used as examples of antimicrobial stewardship.
In this first case study, Dr. Keiji Okinaka (Director of Infection Control and Prevention Section, National Cancer Center Hospital East / Department of General Internal Medicine, National Cancer Center Hospital East /Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital) reports on a case of “A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment.”
For further information, please see the case study below.
Top Research & Recommendations Posts
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Cancer Control Project “Policy Recommendations on Addressing Regional Disparities in Breast Cancer Care” (January 31, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Discussion Points] Intractable & Rare Diseases Project Discussion Paper “Intractable & Rare Diseases 2025: 10 Years After the Passing of the Intractable Diseases Act, Toward a Co-created Future” (Mar 28, 2025)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Public Comment Submission] “2050 Tokyo Strategy: Making Tokyo Even Better (Draft)” (March 3, 2025)
- [Policy Recommendations] Dementia Project Information Packet for Local Government Officials “Dementia Policies for Our City: Taking the First Step in Promoting Future Measures for Dementia” (March 17, 2025)
- [Announcement] HGPI Endorsed “Civil Society’s Expectations for the Continuation and Development of Japan’s Global Health Initiatives” (March 17, 2025)
Featured Posts
-
2025-03-26
[Registration Open] (Webinar) The 132nd HGPI Seminar “Considering the Ideal Evidence-Based Immunization and Vaccination Policies” (April 25, 2025)
-
2025-04-02
[Registration Open] Public Event “The Patient and Citizen Lived Experience Forum 2025” (May 17, 2025)
-
2025-04-17
[Registration Open] (Webinar) The 134th HGPI Seminar “Understanding Evidence-Based Dietary Guidelines: Leveraging the Dietary Reference Intakes for Japanese” (May 28, 2025)
-
2025-04-23
[Registration Open] Recruitment of the Health Policy Academy the 14th Session (Starts July 2025)